EyePoint Pharmaceuticals
EYPT
EYPT
39 hedge funds and large institutions have $20M invested in EyePoint Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
39
Holding in Top 10
–
Calls
$964K
Puts
$239K
Top Buyers
| 1 | +$499K | |
| 2 | +$178K | |
| 3 | +$176K | |
| 4 |
Morgan Stanley
New York
|
+$158K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$91K |
Top Sellers
| 1 | -$503K | |
| 2 | -$141K | |
| 3 | -$95.3K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$77.8K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$74.6K |